World Tumor Marker Testing Market Country Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers
Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years.- Examines trends in the U.S., Europe and Japan- Reviews current and emerging tumor markers- Analyzes applications of emerging diagnostic technologies- Forecasts sales of major tumor markers by country and market segment- Profiles leading market players and potential entrants - Suggests alternative business expansion strategies for suppliers.
Rationale
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.
During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
Geographic Coverage - France- Germany- Italy- Japan- Spain- UK- USA
Market Segmentation Analysis - Sales and market shares of major suppliers, by individual tumor markerand country.- Five-year test volume and sales forecasts for majortumor markers by country and market segment,including:- Hospitals- Commercial/Private Laboratories- Physician Offices/Group Practices- Cancer Clinics- Ambulatory Care Centers
Comprehensive market segmentation analysis, including reviewof the market dynamics, structure, size, growth and major suppliersby country.- Cancer statistics, etiology and recent developments in the U.S., Japan and five major European countries.
Current and Emerging Products - Review of over 200 current and emerging tumor markers,including:- Biochemical Markers- Oncogenes- Growth Factors- Hormones- Colony Stimulating Factors- Lymphokines- Immunohistochemical Stains, and others.- Analysis of major immunoassay analyzers used fortumor marker testing, including their operating characteristics,features and selling prices.
Technology Review - Assessment of monoclonal antibodies, immunoassays, DNAprobes, biochips/microarrays, chromosome analysis, IT,artificial intelligence, flow cytometry, biosensors, and theirpotential applications for tumor marker testing.- Review of competing/complementing technologies, includingCT, MRI, NMR, PET and photonics spectroscopy.- Extensive listings of over 500 companies, universities andresearch centers developing new tumor markers and detection technologies.
Competitive Assessments - Extensive strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborativearrangements and new products in R&D.
Worldwide Market Overview - Estimated universe of laboratories performing tumor marker testingby country.- Five-year test volume and sales projections by country.
Business Opportunities and Strategic Recommendations - Specific new product development opportunities with potentiallysignificant market appeal during the next five years.- Design criteria for new products.- Alternative market penetration strategies.- Potential market entry barriers and risks.
Methodology
This report is based on interviews with clinical pathologists, laboratory directors,executives from leading diagnostic companies and start-up firmsdeveloping innovative products, university scientists, as well asexperts from industry associations, venture capital firms and theinvestment banking community in the U.S., five major European countries and Japan.
The market projections are also based on questionnaireresponses received from hospitals, commercial/private laboratories,physician offices/group practices, cancer clinics and ambulatorycare centers in seven countries.In addition to primary sources of information, a comprehensivereview of the most recent technical and business publications, manufacturerproduct literature, patents, trade association surveys, governmentstudies, marketing and technical meeting presentations, industry analyst reports, and VPGMarketResearchs proprietary data files was conducted.
Contains 1,200 pages and 450 tables
Rationale
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.
During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
Geographic Coverage - France- Germany- Italy- Japan- Spain- UK- USA
Market Segmentation Analysis - Sales and market shares of major suppliers, by individual tumor markerand country.- Five-year test volume and sales forecasts for majortumor markers by country and market segment,including:- Hospitals- Commercial/Private Laboratories- Physician Offices/Group Practices- Cancer Clinics- Ambulatory Care Centers
Comprehensive market segmentation analysis, including reviewof the market dynamics, structure, size, growth and major suppliersby country.- Cancer statistics, etiology and recent developments in the U.S., Japan and five major European countries.
Current and Emerging Products - Review of over 200 current and emerging tumor markers,including:- Biochemical Markers- Oncogenes- Growth Factors- Hormones- Colony Stimulating Factors- Lymphokines- Immunohistochemical Stains, and others.- Analysis of major immunoassay analyzers used fortumor marker testing, including their operating characteristics,features and selling prices.
Technology Review - Assessment of monoclonal antibodies, immunoassays, DNAprobes, biochips/microarrays, chromosome analysis, IT,artificial intelligence, flow cytometry, biosensors, and theirpotential applications for tumor marker testing.- Review of competing/complementing technologies, includingCT, MRI, NMR, PET and photonics spectroscopy.- Extensive listings of over 500 companies, universities andresearch centers developing new tumor markers and detection technologies.
Competitive Assessments - Extensive strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborativearrangements and new products in R&D.
Worldwide Market Overview - Estimated universe of laboratories performing tumor marker testingby country.- Five-year test volume and sales projections by country.
Business Opportunities and Strategic Recommendations - Specific new product development opportunities with potentiallysignificant market appeal during the next five years.- Design criteria for new products.- Alternative market penetration strategies.- Potential market entry barriers and risks.
Methodology
This report is based on interviews with clinical pathologists, laboratory directors,executives from leading diagnostic companies and start-up firmsdeveloping innovative products, university scientists, as well asexperts from industry associations, venture capital firms and theinvestment banking community in the U.S., five major European countries and Japan.
The market projections are also based on questionnaireresponses received from hospitals, commercial/private laboratories,physician offices/group practices, cancer clinics and ambulatorycare centers in seven countries.In addition to primary sources of information, a comprehensivereview of the most recent technical and business publications, manufacturerproduct literature, patents, trade association surveys, governmentstudies, marketing and technical meeting presentations, industry analyst reports, and VPGMarketResearchs proprietary data files was conducted.
Contains 1,200 pages and 450 tables
I. INTRODUCTION
II. WORLDWIDE MARKET OVERVIEW
1. MARKET O5ER6EW
2. WORLDW1DE MARKET STRUCTURE
3. WORLDW1DE MARKET S1ZE AND GROWTH
III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Reagent Kits and Test Systems/Panels
B. 1nstrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
V. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Cancer Statistics and Etiology
1. BREAST CANCER
2. LUNG CANCER
3. COLON AND RECTUM CANCER
4. PROSTATE CANCER
5. STOMACH CANCER
6. LEUKEM1A
7. LYMPHOMA
8. ORAL CANCER
9. SK1N CANCER
10. UTER1NE CANCER
11. O5AR1AN CANCER
12. BLADDER CANCER
B. Major Current And Emerging Cancer Diagnostic Tests
1. 1NTRODUCT1ON
2. TUMOR MARKER CLASS1F1CAT1ON
3. ACTH
4. ALPHA-FETOPROTE1N (AFP)
5. BETA-2 M1CROGLOBUL1N
6. CA 15-3/27.29
7. CA 19-9
8. CA-125
9. CALC1TON1N
10. CARC1NOEMBR1ON1C ANT1GEN (CEA)
11. ESTROGEN AND PROGESTERONE RECEPTORS
12. FERR1T1N
13. GASTR1N
14. HUMAN CHOR1ON1C GONADOTROP1N (HCG)
15. 1NSUL1N
16. NSE
17. OCCULT BLOOD
18. PAP SMEAR/HP5
19. PROSTAT1C AC1D PHOSPHATASE (PAP)
20. PROSTATE-SPEC1F1C ANT1GEN (PSA)
21. SQUAMOUS CELL CARC1NOMA ANT1GEN (SCC)
22. T AND B LYMPHOCYTES
23. TDT
24. THYROGLOBUL1N
25. T1SSUE POLYPEPT1DE ANT1GEN (TPA)
26. B1OCHEM1CAL TUMOR MARKERS
27. ONCOGENES
Abl/abl-bcr
A1B1
BCL-2
BRCA1
CD44
C-fos
C-myb
C-myc
CYP-17
Erb-B
HPC1
N-myc
P40
P51
P53
P1K3CA
PT1-1
Ras
Reg
Sis
Src
28. POLYPEPT1DE GROWTH FACTORS
Basic Fibroblast Growth Factor
Beta-TGF
Cachectin (TNT)
Calmodulin
ECFR
Nerve Growth Factor (NGF)
Epidermal Growth Factor (EGF)
Ornithine Decarboxylase
Transferrin
Transforming Growth Factor-Alpha
29. ECTOP1C HORMONES
30. COLONY ST1MULAT1NG FACTORS
31. LYMPHOK1NES
Alpha-1nterferon
B Cell Growth Factors
B Cell Growth Factor (BCGF)
Gamma-1nterferon
1nterleukin-1 (1L-1)
Macrophage Activating Factor
32. 1MMUNOH1STOCHEM1CAL STA1NS
33. EMERG1NG TUMOR MARKERS
N-Acetylglucosamine
Actin
Alpha-Actin
Antineuronal Antibodies
7B2
B72.3
Bax
BCD-F9
BLCA-4
Blood Group Antigens A,B,H
CA
CA 72-4/TAG-72
CA
CA-242
CA-549
CAM
CAR-3
Cathepsin-D
Chromogranin A and B
Cluster 1 Antigen
Cluster-5/5A Antigen
CTA
CU18
DR-70
DU-PAN-2
Endometrial Bleeding Associated Factor
Endostatin
Epithelial Membrane Antigen
Feulgen Hydrolysis
Fibronectin
FSH
(1->3)-L-fucosyltransferase
Gastrin-Releasing Peptide (GRP)
GDCFP-15
Glucagon
Glycoamines
H23
Her-2
Human Carcinoma Antigen
HPA
HSP27
1ntermediate Filaments
Cytokeratins/CK18/Cyfra 21-1
Desmin
Gliofibrillary Acid Protein
Neurofilaments
5imentin
KA
Kinases
KP16D3
LA1
Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma
MABDF3
MAG
ME1
Minactivin
MN/CA9
MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor
Myosin
NEA-130
NMP22
OA-519
Opioid Peptides
P-glycoprotein
Pancreatic Oncofetal Antigen (POA)
Placental Lactogen
PR92
Proliferative 1ndex, Ki-67
Px
RB 1nactivation/Deletion
Ret
SCCL
Selectin
Sialic AcHSP27
1ntermediate Filaments
Cytokeratins/CK18/Cyfra 21-1
Desmin
Gliofibrillary Acid Protein
Neurofilaments
5imentin
KA
Kinases
KP16D3LA1
Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma
MABDF3MAGME1
Minactivin
MN/CA9MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor
Myosin
NEA-130NMP22OA-519
Opioid Peptides
P-glycoprotein
Pancreatic Oncofetal Antigen (POA)
Placental Lactogen
PR92
Proliferative 1ndex, Ki-67
Px
RB 1nactivation/Deletion
Ret
SCCL
Selectin
Sialic Acid
Sialyl SSEA-1/SL10
SN10
Somatostatin
TA-90TABA
Tachykinin
TAGTPS
Troponin
Tubulin
5CAM5EGF
5illen
C. Cancer Diagnostic Testing 1nstrumentation Review and Market Needs
D. Current and Emerging Cancer Diagnostic Technologies
1. MONOCLONAL AND POLYCLONAL ANT1BOD1ES
2. 1MMUNOASSAYS
3. MOLECULAR D1AGNOST1CS
4. CHROMOSOME ANALYS1S
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. ART1F1C1AL 1NTELL1GENCE
6. FLOW CYTOMETRY
7. TWO D1MENS1ONAL GEL ELECTROPHORES1S (2-DGE)
8. B1OSENSORS
9. COMPET1NG/COMPLEMENT1NG TECHNOLOG1ES
E. Personal Testing
VIII. FRANCE CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
IX. GERMANY CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
X. ITALY CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
XI. JAPAN CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
XII. SPAIN CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
XIII. U.K. CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
XIV. U.S. CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
XV. COMPETITIVE PROFILES
Abbott
AdnaGen/Alere
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/5ermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/Gen-Probe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Thermo
5eridex
Wako Pure Chemicals
Wallac/PE
Zila
XVI. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS
L1ST OF TABLES
Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing 1nsulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HP5 Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications 1n Cancer Diagnosis
Oncogenes Potential Applications 1n Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications 1n Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications 1n Cancer Diagnosis
1MMUNOHISTOCHEMICAL STAINS POTENTIAL APPLICATIONS IN CANCER DIAGNOSIS
Executive Summary Table: France, Total Cancer Diagnostic Test 5olume and Sales Forecast by Market Segment
France, Estimated Cancer Death Rates Per 100,000 Population
France, Laboratories Performing Tumor Marker Tests by Market Segment
France, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
France, Commercial/Private Laboratories Performing Tumor Markers by Annual Test 5olume
France, Total Tumor Marker Test 5olume Forecast by Market Segment
France, All Market Segments Major Tumor Marker Test 5olume Forecast
France, Hospital Laboratories Major Tumor Marker Test 5olume Forecast by Test
France, Commercial/Private Laboratories Marker Test 5olume Forecast
France, Total Tumor Marker Sales Major Tumor Forecast by Market Segment
France, All Market Segments Major Tumor Marker Sales Forecast by Test
France, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
France, Commercial/Private Laboratories Cancer Diagnostics Market Forecast by Test
France, ACTH Test 5olume and Diagnostics Sales Forecast by Market Segment
France, AFP Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Beta-2 Microglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, CA 15-3/27.29 Test 5olume and Diagnostics Sales Forecast by Market Segment
France, CA 19-9 Test 5olume and Diagnostics Sales Forecast by Market
France, CA-125 Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Calcitonin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Cathepsin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, CEA Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Colon-Specific Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Cytokeratins Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Estrogen Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Ferritin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Gastrin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, HCG Test 5olume and Diagnostics Sales Forecast by Market Segment
France, 1nsulin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, 1nterferons Test 5olume and Diagnostics Sales Forecast by Market Segment
France, 1nterleukins Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Lymphocyte Subtyping Test 5olume and Diagnostics Sales Forecast by Market Segment
France, NSE Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Nucleolar Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Occult Blood Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Oncogenes Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Pancreatic Oncofetal Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
France, PAP Smear Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Parathyroid Hormone Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Progesterone Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
France, PAP Test 5olume and Diagnostics Sales Forecast by Market Segment
France, PSA Test 5olume and Diagnostics Sales Forecast by Market Segment
France, S-100 Protein Test 5olume and Sales Diagnostics Sales Forecast by Market Segment
France, Serotonin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Sialic Acid Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Squamous Cell Carcinoma Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
France, TDT Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Thymidine Kinase Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Thyroglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, TPA Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Total Tumor Marker Sales By Major Suppliers
France, AFP Testing Market Diagnostics Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
France, CA 125 Testing Market Diagnostics Sales by Major Supplier
France, CEA Testing Market Diagnostics Sales by Major Supplier
France, NSE Testing Market Diagnostics Sales by Major Supplier
France, PAP Testing Market Diagnostics Sales by Major Supplier
France, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Germany, Total Tumor Marker Test 5olume and Sales Forecast By Market Segment
Germany, Estimated Cancer Death Rates Per 100,000 Population
Germany, Laboratories Performing Tumor Marker Tests by Market Segment
Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Germany, Commercial/Private Laboratories Performing Tumor Markers by Annual Test 5olume
Germany, Total Tumor Marker Test 5olume Forecast by Market Segment
Germany, All Market Segments, Major Tumor Marker Test 5olume Forecast
Germany, Hospital Laboratories, Major Tumor Marker Test 5olume Forecast by Test
Germany, Commercial/Private Laboratories Major Tumor Marker Test 5olume Forecast
Germany, Physician Offices/Group Practices Major Tumor Marker Test 5olume Forecast
Germany, Total Tumor Marker Sales Forecast by Market Segment
Germany, All Market Segments Major Tumor Marker Sales Forecast by Test
Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test
Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
Germany, ACTH Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, AFP Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Beta-2 Microglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, CA-15-3/27.29 Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, CA-19 Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, CA 125 Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Calcitonin Test 5olume and Diagnostic Sales Forecast by Market Segment
Germany, Cathepsin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, CEA Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Chromogranin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Colon-Specific Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Cytokeratins Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Estrogen Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Ferritin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Gastrin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, HCG, Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, 1nsulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, 1nterferons Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, 1nterleukins Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Lymphocyte Subtyping Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, NSE Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Occult Blood Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Oncogenes Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Pancreatic Oncofetal Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Pap Smear Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Parathyroid Hormone Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Progesterone Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, PAP Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, PSA Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, S-100 Protein Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Serotonin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Sialic Acid Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Squamous Cell Carcinoma Antigen Test 5olume and Diagnostics Sales Forecast By Market Segment
Germany, TDT Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Thymidine Kinase Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Thyroglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, TPA Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Total Tumor Marker Sales By Major Supplier
Germany, AFP Testing Market Diagnostics Sales by Major Supplier
Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
Germany, CEA Testing Market Diagnostics Sales by Major Supplier
Germany, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: 1taly, Total Tumor Marker Test 5olume and Diagnostics Sales Forecast by Market Segment
ITALY, ESTIMATED CANCER DEATH RATES PER 100,000 POPULATION
ITALY, LABORATORIES PERFORMING TUMOR MARKER TESTS BY MARKET SEGMENT
ITALY, HOSPITAL LABORATORIES PERFORMING TUMOR MARKER TESTS BY BED SIZE
ITALY, COMMERCIAL/PRIVATE LABORATORIES PERFORMING TUMOR MARKERS BY ANNUAL TEST 5OLUME
ITALY, TOTAL TUMOR MARKER TEST 5OLUME FORECAST BY MARKET SEGMENT
ITALY, ALL MARKET SEGMENTS MAJOR CANCER DIAGNOSTIC TEST 5OLUME FORECAST
ITALY, HOSPITAL LABORATORIES MAJOR TUMOR MARKER TEST 5OLUME FORECAST
ITALY, COMMERCIAL/PRIVATE LABORATORIES MAJOR TUMOR MARKER TEST 5OLUME FORECAST
ITALY, TOTAL TUMOR MARKER TEST MARKET FORECAST BY MARKET SEGMENT
ITALY, ALL MARKET SEGMENTS MAJOR TUMOR MARKER SALES FORECAST BY TEST
ITALY, HOSPITAL LABORATORIES MAJOR TUMOR MARKER FORECAST BY TEST
ITALY, COMMERCIAL/PRIVATE LABORATORIES MAJOR TUMOR MARKER SALES FORECAST BY TEST
ITALY, ACTH TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, AFP TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, BETA-2 MICROGLOBULIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, CA 15-3/27.29 TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, CA-19-9 TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, CA 125 TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, CALCITONIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, CEA TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, CHROMOGRANIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, COLON SPECIFIC ANTIGEN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, CYTOKERATINS TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, ESTROGEN RECEPTOR TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, FERRITIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, GASTRIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, HCG TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, 1NSULIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, LYMPHOCYTE SUBTYPING TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, NSE TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, OCCULT BLOOD TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, ONCOGENES TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, PANCREATIC ONCOFETAL ANTIGEN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, PAP SMEAR TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, PARATHYROID HORMONE TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, PROGESTERONE RECEPTOR TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, PAP TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, PSA TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, S-100 TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, SEROTONIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, SIALIC ACID TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, SQUAMOUS CELL CARCINOMA ANTIGEN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, TDT TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, THYMIDINE KINASE TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, THYROGLOBULIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, TPA TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, TOTAL TUMOR MARKERS SALES BY MAJOR SUPPLIERS
ITALY, AFP TESTING MARKET DIAGNOSTICS SALES BY MAJOR SUPPLIER
ITALY, CEA TESTING MARKET DIAGNOSTICS SALES BY MAJOR SUPPLIER
ITALY, PSA TESTING MARKET DIAGNOSTICS SALES BY MAJOR SUPPLIER
Executive Summary Table: Japan, Total Tumor Marker Test 5olume and Sales Forecast by Market Segment
Japan, Estimated Cancer Death Rates Per 100,000 Population
Japan, Laboratories Performing Tumor Marker Tests by Market Segment
Japan, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Japan, Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test 5olume
Japan, Total Tumor Marker Testing 5olume Forecast by Market Segment
Japan, All Market Segments Major Tumor Marker Test 5olume Forecast
Japan, Hospital Laboratories Major Tumor Marker Test 5olume Forecast by Test
Japan, Commercial/Private Laboratories Major Tumor Marker Test 5olume Forecast
Japan, Total Tumor Marker Sales Forecast by Market Segment
Japan, All Market Segments Major Tumor Marker Sales Forecast by Test
Japan, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
Japan, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Japan, ACTH Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, AFP Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Beta-2 Microglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, CA 15-3/27.29 Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, CA 19-9 Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, CA-125 Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Calcitonin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Cathepsin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, CEA Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Chromogranin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Colon-Specific Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Cytokeratins Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Estrogen Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Ferritin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Gastrin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, HCG Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, 1nsulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, 1nterferons Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, 1nterleukins Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Lymphocyte Subtyping Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, NSE Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Nucleolar Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Occult Blood Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Oncogenes Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Pancreatic Oncofetal Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, PAP Smear Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Parathyroid Hormone Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Progesterone Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, PAP Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, PSA Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, S-100 Protein Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Serotonin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Sialic Acid Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Squamous Cell Carcinoma Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, TDT Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Thymidine Kinase Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Thyroglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, TPA, Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Total Tumor Marker Sales by Major Suppliers
Japan, AFP Testing Market Diagnostics Sales by Major Supplier
Japan, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Japan, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics Sales by Major Supplier
Japan, PAP Testing Market Diagnostics Sales by Major Supplier
Japan, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Spain, Total Tumor Marker Test 5olume and Sales Forecast by Market Segment
Spain, Estimated Cancer Death Rates Per 100,000 Population
Spain, Laboratories Performing Tumor Marker Tests by Market Segment
Spain, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Spain, Commercial/Private Laboratories Performing Tumor Markers by Annual Test 5olume
Spain, Total Tumor Marker Test 5olume Forecast by Market Segment
Spain, All Market Segment Major Cancer Diagnostic Test 5olume Forecast
Spain, Hospital Laboratories Major Cancer Diagnostic Test 5olume Forecast by Test
Spain, Commercial/Private Laboratories Major Tumor Marker Test 5olume Forecast
Spain, Total Tumor Marker Sales Forecast by Market Segment
Spain, All Market Segments Major Tumor Marker Sales Forecast by Test
Spain, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
Spain, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Spain, AFP Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Beta-2 Microglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, CA 15-3 Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, CA 19-9 Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, CA-125 Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Calcitonin Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, CEA Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Colon-Specific Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Estrogen Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Ferritin Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Gastrin Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, HCG Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, 1nsulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Lymphocyte Subtyping Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, NSE Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Occult Blood Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Oncogenes Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Pancreatic Oncofetal Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, PAP Smear Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Parathyroid Hormone Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Progesterone Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, PAP Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, PSA Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, S-100 Protein Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Serotonin Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Sialic Acid Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Squamous Cell Carcinoma Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, TDT Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Thymidine Kinase Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Thyroglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, TPA Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Total Tumor Marker Sales by Major Suppliers
Spain, AFP Testing Market Diagnostics Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
Spain, CEA Testing Market Diagnostics Sales by Major Supplier
Spain, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: U.K., Total Tumor Marker Test 5olume and Sales Forecast by Market Segment
U.K., Estimated Cancer Death Rates Per 100,000 Population
U.K., Laboratories Performing Tumor Marker Tests by Market Segment
U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test 5olume
U.K., Total Tumor Marker Testing 5olume Forecast by Market Segment
U.K., All Market Segments Major Tumor Marker Test 5olume Forecast
U.K., Hospital Laboratories Major Tumor Marker Test 5olume Forecast by Test
U.K., Commercial/Private Laboratories Major Tumor Marker Test 5olume Forecast
U.K., Total Tumor Marker Sales Forecast by Market Segment
U.K., All Market Segments Major Tumor Marker Sales Forecast by Test
U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
U.K., ACTH Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., AFP Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Beta-2 Microglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., CA 15-3/27.29 Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., CA 19-9 Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., CA-125 Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Calcitonin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., CEA Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Chromogranin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Colon-Specific Antigen Test 5olume and Diagnostics Sales by Market Segment
U.K., Cytokeratins Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Estrogen Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Ferritin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Gastrin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., HCG Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., 1nsulin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Lymphocyte Subtyping Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., NSE Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Occult Blood Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Oncogenes Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Pancreatic Oncofetal Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., PAP Smear Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Parathyroid Hormone Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Progesterone Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., PAP Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., PSA Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., S-100 Protein Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Serotonin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Sialic Acid Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Squamous Cell Carcinoma Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., TDT Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Thymidine Kinase Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Thyroglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., TPA Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Total Tumor Marker Sales and Market Shares Forecast
U.K., CEA Testing Market Diagnostics Sales by Major Supplier
U.K., PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: U.S., Total Tumor Marker Test 5olume and Sales Forecast By Market Segment
U.S., Estimated New Cancer Cases and Deaths
U.S., Estimated Cancer Death Rates Per 100,000 Population
U.S., Laboratories Performing Tumor Marker Tests by Market Segment
U.S., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
U.S., Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test 5olume
U.S., Physician Office Laboratories Performing Tumor Marker Tests By Practice Size
U.S., Total Tumor Marker Test 5olume Forecast by Market Segment
U.S., All Market Segments Major Tumor Marker Test 5olume Forecast
U.S., Hospital Laboratories Major Tumor Marker Test 5olume Forecast by Test
U.S., Commercial/Private Laboratories Major Tumor Marker Test 5olume Forecast
U.S., Physician Offices/Group Practices Major Tumor Marker Test 5olume Forecast
U.S., Cancer Clinics Major Tumor Marker Test 5olume Forecast by Test
U.S., Total Tumor Marker Sales Forecast by Market Segment
U.S., All Market Segment Major Tumor Marker Sales Forecast by Test
U.S., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
U.S., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
U.S., Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
U.S., Cancer Clinics Major Tumor Marker Sales Forecast by Test
U.S., ACTH Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., AFP Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Beta-2 Microglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., CA 15-3/27.29 Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., CA 19-9 Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., CA-125 Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Calcitonin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Cathepsin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., CEA Test 5olume and Diagnostics Sales by Market Segment
U.S., Chromogranin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Colon-specific Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Cytokeratins Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Estrogen Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Ferritin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Gastrin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., HCG Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., 1nsulin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., 1nterferons Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., 1nterleukins Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Lymphocyte Subtyping Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., NSE Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Nucleolar Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Occult Blood Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Oncogenes Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Pancreatic Oncofetal Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., PAP Smear Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Parathyroid Hormone Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Progesterone Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., PAP Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., PSA Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., S-100 Protein Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Serotonin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Sialic Acid Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Squamous Cell Carcinoma Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., TDT Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Thymidine Kinase Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Thyroglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., TPA Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Total Tumor Marker Sales By Major Supplier
U.S., ACTH Testing Market Diagnostics Sales by Major Supplier
U.S., AFP Testing Market Diagnostics Sales by Major Supplier
U.S., Beta-2 Migroblolulin Testing Market Diagnostics Sales by Major Supplier
U.S., CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 19-9 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier
U.S., CEA Testing Market Diagnostics Sales by Major Supplier
U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier
U.S., HCG Testing Market Diagnostics Sales by Major Supplier
U.S., 1nsulin Testing Market Diagnostics Sales by Major Supplier
U.S., Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
U.S., PAP Testing Market Diagnostics Sales by Major Supplier
U.S., Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
U.S., PSA Testing Market Diagnostics Sales by Major Supplier
II. WORLDWIDE MARKET OVERVIEW
1. MARKET O5ER6EW
2. WORLDW1DE MARKET STRUCTURE
3. WORLDW1DE MARKET S1ZE AND GROWTH
III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Reagent Kits and Test Systems/Panels
B. 1nstrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
V. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Cancer Statistics and Etiology
1. BREAST CANCER
2. LUNG CANCER
3. COLON AND RECTUM CANCER
4. PROSTATE CANCER
5. STOMACH CANCER
6. LEUKEM1A
7. LYMPHOMA
8. ORAL CANCER
9. SK1N CANCER
10. UTER1NE CANCER
11. O5AR1AN CANCER
12. BLADDER CANCER
B. Major Current And Emerging Cancer Diagnostic Tests
1. 1NTRODUCT1ON
2. TUMOR MARKER CLASS1F1CAT1ON
3. ACTH
4. ALPHA-FETOPROTE1N (AFP)
5. BETA-2 M1CROGLOBUL1N
6. CA 15-3/27.29
7. CA 19-9
8. CA-125
9. CALC1TON1N
10. CARC1NOEMBR1ON1C ANT1GEN (CEA)
11. ESTROGEN AND PROGESTERONE RECEPTORS
12. FERR1T1N
13. GASTR1N
14. HUMAN CHOR1ON1C GONADOTROP1N (HCG)
15. 1NSUL1N
16. NSE
17. OCCULT BLOOD
18. PAP SMEAR/HP5
19. PROSTAT1C AC1D PHOSPHATASE (PAP)
20. PROSTATE-SPEC1F1C ANT1GEN (PSA)
21. SQUAMOUS CELL CARC1NOMA ANT1GEN (SCC)
22. T AND B LYMPHOCYTES
23. TDT
24. THYROGLOBUL1N
25. T1SSUE POLYPEPT1DE ANT1GEN (TPA)
26. B1OCHEM1CAL TUMOR MARKERS
27. ONCOGENES
Abl/abl-bcr
A1B1
BCL-2
BRCA1
CD44
C-fos
C-myb
C-myc
CYP-17
Erb-B
HPC1
N-myc
P40
P51
P53
P1K3CA
PT1-1
Ras
Reg
Sis
Src
28. POLYPEPT1DE GROWTH FACTORS
Basic Fibroblast Growth Factor
Beta-TGF
Cachectin (TNT)
Calmodulin
ECFR
Nerve Growth Factor (NGF)
Epidermal Growth Factor (EGF)
Ornithine Decarboxylase
Transferrin
Transforming Growth Factor-Alpha
29. ECTOP1C HORMONES
30. COLONY ST1MULAT1NG FACTORS
31. LYMPHOK1NES
Alpha-1nterferon
B Cell Growth Factors
B Cell Growth Factor (BCGF)
Gamma-1nterferon
1nterleukin-1 (1L-1)
Macrophage Activating Factor
32. 1MMUNOH1STOCHEM1CAL STA1NS
33. EMERG1NG TUMOR MARKERS
N-Acetylglucosamine
Actin
Alpha-Actin
Antineuronal Antibodies
7B2
B72.3
Bax
BCD-F9
BLCA-4
Blood Group Antigens A,B,H
CA
CA 72-4/TAG-72
CA
CA-242
CA-549
CAM
CAR-3
Cathepsin-D
Chromogranin A and B
Cluster 1 Antigen
Cluster-5/5A Antigen
CTA
CU18
DR-70
DU-PAN-2
Endometrial Bleeding Associated Factor
Endostatin
Epithelial Membrane Antigen
Feulgen Hydrolysis
Fibronectin
FSH
(1->3)-L-fucosyltransferase
Gastrin-Releasing Peptide (GRP)
GDCFP-15
Glucagon
Glycoamines
H23
Her-2
Human Carcinoma Antigen
HPA
HSP27
1ntermediate Filaments
Cytokeratins/CK18/Cyfra 21-1
Desmin
Gliofibrillary Acid Protein
Neurofilaments
5imentin
KA
Kinases
KP16D3
LA1
Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma
MABDF3
MAG
ME1
Minactivin
MN/CA9
MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor
Myosin
NEA-130
NMP22
OA-519
Opioid Peptides
P-glycoprotein
Pancreatic Oncofetal Antigen (POA)
Placental Lactogen
PR92
Proliferative 1ndex, Ki-67
Px
RB 1nactivation/Deletion
Ret
SCCL
Selectin
Sialic AcHSP27
1ntermediate Filaments
Cytokeratins/CK18/Cyfra 21-1
Desmin
Gliofibrillary Acid Protein
Neurofilaments
5imentin
KA
Kinases
KP16D3LA1
Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma
MABDF3MAGME1
Minactivin
MN/CA9MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor
Myosin
NEA-130NMP22OA-519
Opioid Peptides
P-glycoprotein
Pancreatic Oncofetal Antigen (POA)
Placental Lactogen
PR92
Proliferative 1ndex, Ki-67
Px
RB 1nactivation/Deletion
Ret
SCCL
Selectin
Sialic Acid
Sialyl SSEA-1/SL10
SN10
Somatostatin
TA-90TABA
Tachykinin
TAGTPS
Troponin
Tubulin
5CAM5EGF
5illen
C. Cancer Diagnostic Testing 1nstrumentation Review and Market Needs
D. Current and Emerging Cancer Diagnostic Technologies
1. MONOCLONAL AND POLYCLONAL ANT1BOD1ES
2. 1MMUNOASSAYS
3. MOLECULAR D1AGNOST1CS
4. CHROMOSOME ANALYS1S
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. ART1F1C1AL 1NTELL1GENCE
6. FLOW CYTOMETRY
7. TWO D1MENS1ONAL GEL ELECTROPHORES1S (2-DGE)
8. B1OSENSORS
9. COMPET1NG/COMPLEMENT1NG TECHNOLOG1ES
E. Personal Testing
VIII. FRANCE CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
IX. GERMANY CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
X. ITALY CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
XI. JAPAN CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
XII. SPAIN CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
XIII. U.K. CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
XIV. U.S. CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
XV. COMPETITIVE PROFILES
Abbott
AdnaGen/Alere
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/5ermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/Gen-Probe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Thermo
5eridex
Wako Pure Chemicals
Wallac/PE
Zila
XVI. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS
L1ST OF TABLES
Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing 1nsulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HP5 Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications 1n Cancer Diagnosis
Oncogenes Potential Applications 1n Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications 1n Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications 1n Cancer Diagnosis
1MMUNOHISTOCHEMICAL STAINS POTENTIAL APPLICATIONS IN CANCER DIAGNOSIS
Executive Summary Table: France, Total Cancer Diagnostic Test 5olume and Sales Forecast by Market Segment
France, Estimated Cancer Death Rates Per 100,000 Population
France, Laboratories Performing Tumor Marker Tests by Market Segment
France, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
France, Commercial/Private Laboratories Performing Tumor Markers by Annual Test 5olume
France, Total Tumor Marker Test 5olume Forecast by Market Segment
France, All Market Segments Major Tumor Marker Test 5olume Forecast
France, Hospital Laboratories Major Tumor Marker Test 5olume Forecast by Test
France, Commercial/Private Laboratories Marker Test 5olume Forecast
France, Total Tumor Marker Sales Major Tumor Forecast by Market Segment
France, All Market Segments Major Tumor Marker Sales Forecast by Test
France, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
France, Commercial/Private Laboratories Cancer Diagnostics Market Forecast by Test
France, ACTH Test 5olume and Diagnostics Sales Forecast by Market Segment
France, AFP Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Beta-2 Microglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, CA 15-3/27.29 Test 5olume and Diagnostics Sales Forecast by Market Segment
France, CA 19-9 Test 5olume and Diagnostics Sales Forecast by Market
France, CA-125 Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Calcitonin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Cathepsin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, CEA Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Colon-Specific Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Cytokeratins Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Estrogen Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Ferritin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Gastrin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, HCG Test 5olume and Diagnostics Sales Forecast by Market Segment
France, 1nsulin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, 1nterferons Test 5olume and Diagnostics Sales Forecast by Market Segment
France, 1nterleukins Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Lymphocyte Subtyping Test 5olume and Diagnostics Sales Forecast by Market Segment
France, NSE Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Nucleolar Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Occult Blood Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Oncogenes Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Pancreatic Oncofetal Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
France, PAP Smear Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Parathyroid Hormone Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Progesterone Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
France, PAP Test 5olume and Diagnostics Sales Forecast by Market Segment
France, PSA Test 5olume and Diagnostics Sales Forecast by Market Segment
France, S-100 Protein Test 5olume and Sales Diagnostics Sales Forecast by Market Segment
France, Serotonin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Sialic Acid Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Squamous Cell Carcinoma Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
France, TDT Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Thymidine Kinase Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Thyroglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
France, TPA Test 5olume and Diagnostics Sales Forecast by Market Segment
France, Total Tumor Marker Sales By Major Suppliers
France, AFP Testing Market Diagnostics Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
France, CA 125 Testing Market Diagnostics Sales by Major Supplier
France, CEA Testing Market Diagnostics Sales by Major Supplier
France, NSE Testing Market Diagnostics Sales by Major Supplier
France, PAP Testing Market Diagnostics Sales by Major Supplier
France, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Germany, Total Tumor Marker Test 5olume and Sales Forecast By Market Segment
Germany, Estimated Cancer Death Rates Per 100,000 Population
Germany, Laboratories Performing Tumor Marker Tests by Market Segment
Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Germany, Commercial/Private Laboratories Performing Tumor Markers by Annual Test 5olume
Germany, Total Tumor Marker Test 5olume Forecast by Market Segment
Germany, All Market Segments, Major Tumor Marker Test 5olume Forecast
Germany, Hospital Laboratories, Major Tumor Marker Test 5olume Forecast by Test
Germany, Commercial/Private Laboratories Major Tumor Marker Test 5olume Forecast
Germany, Physician Offices/Group Practices Major Tumor Marker Test 5olume Forecast
Germany, Total Tumor Marker Sales Forecast by Market Segment
Germany, All Market Segments Major Tumor Marker Sales Forecast by Test
Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test
Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
Germany, ACTH Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, AFP Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Beta-2 Microglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, CA-15-3/27.29 Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, CA-19 Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, CA 125 Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Calcitonin Test 5olume and Diagnostic Sales Forecast by Market Segment
Germany, Cathepsin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, CEA Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Chromogranin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Colon-Specific Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Cytokeratins Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Estrogen Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Ferritin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Gastrin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, HCG, Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, 1nsulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, 1nterferons Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, 1nterleukins Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Lymphocyte Subtyping Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, NSE Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Occult Blood Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Oncogenes Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Pancreatic Oncofetal Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Pap Smear Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Parathyroid Hormone Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Progesterone Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, PAP Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, PSA Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, S-100 Protein Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Serotonin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Sialic Acid Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Squamous Cell Carcinoma Antigen Test 5olume and Diagnostics Sales Forecast By Market Segment
Germany, TDT Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Thymidine Kinase Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Thyroglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, TPA Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Total Tumor Marker Sales By Major Supplier
Germany, AFP Testing Market Diagnostics Sales by Major Supplier
Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
Germany, CEA Testing Market Diagnostics Sales by Major Supplier
Germany, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: 1taly, Total Tumor Marker Test 5olume and Diagnostics Sales Forecast by Market Segment
ITALY, ESTIMATED CANCER DEATH RATES PER 100,000 POPULATION
ITALY, LABORATORIES PERFORMING TUMOR MARKER TESTS BY MARKET SEGMENT
ITALY, HOSPITAL LABORATORIES PERFORMING TUMOR MARKER TESTS BY BED SIZE
ITALY, COMMERCIAL/PRIVATE LABORATORIES PERFORMING TUMOR MARKERS BY ANNUAL TEST 5OLUME
ITALY, TOTAL TUMOR MARKER TEST 5OLUME FORECAST BY MARKET SEGMENT
ITALY, ALL MARKET SEGMENTS MAJOR CANCER DIAGNOSTIC TEST 5OLUME FORECAST
ITALY, HOSPITAL LABORATORIES MAJOR TUMOR MARKER TEST 5OLUME FORECAST
ITALY, COMMERCIAL/PRIVATE LABORATORIES MAJOR TUMOR MARKER TEST 5OLUME FORECAST
ITALY, TOTAL TUMOR MARKER TEST MARKET FORECAST BY MARKET SEGMENT
ITALY, ALL MARKET SEGMENTS MAJOR TUMOR MARKER SALES FORECAST BY TEST
ITALY, HOSPITAL LABORATORIES MAJOR TUMOR MARKER FORECAST BY TEST
ITALY, COMMERCIAL/PRIVATE LABORATORIES MAJOR TUMOR MARKER SALES FORECAST BY TEST
ITALY, ACTH TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, AFP TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, BETA-2 MICROGLOBULIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, CA 15-3/27.29 TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, CA-19-9 TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, CA 125 TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, CALCITONIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, CEA TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, CHROMOGRANIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, COLON SPECIFIC ANTIGEN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, CYTOKERATINS TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, ESTROGEN RECEPTOR TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, FERRITIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, GASTRIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, HCG TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, 1NSULIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, LYMPHOCYTE SUBTYPING TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, NSE TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, OCCULT BLOOD TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, ONCOGENES TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, PANCREATIC ONCOFETAL ANTIGEN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, PAP SMEAR TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, PARATHYROID HORMONE TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, PROGESTERONE RECEPTOR TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, PAP TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, PSA TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, S-100 TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, SEROTONIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, SIALIC ACID TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, SQUAMOUS CELL CARCINOMA ANTIGEN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, TDT TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, THYMIDINE KINASE TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, THYROGLOBULIN TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, TPA TEST 5OLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
ITALY, TOTAL TUMOR MARKERS SALES BY MAJOR SUPPLIERS
ITALY, AFP TESTING MARKET DIAGNOSTICS SALES BY MAJOR SUPPLIER
ITALY, CEA TESTING MARKET DIAGNOSTICS SALES BY MAJOR SUPPLIER
ITALY, PSA TESTING MARKET DIAGNOSTICS SALES BY MAJOR SUPPLIER
Executive Summary Table: Japan, Total Tumor Marker Test 5olume and Sales Forecast by Market Segment
Japan, Estimated Cancer Death Rates Per 100,000 Population
Japan, Laboratories Performing Tumor Marker Tests by Market Segment
Japan, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Japan, Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test 5olume
Japan, Total Tumor Marker Testing 5olume Forecast by Market Segment
Japan, All Market Segments Major Tumor Marker Test 5olume Forecast
Japan, Hospital Laboratories Major Tumor Marker Test 5olume Forecast by Test
Japan, Commercial/Private Laboratories Major Tumor Marker Test 5olume Forecast
Japan, Total Tumor Marker Sales Forecast by Market Segment
Japan, All Market Segments Major Tumor Marker Sales Forecast by Test
Japan, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
Japan, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Japan, ACTH Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, AFP Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Beta-2 Microglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, CA 15-3/27.29 Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, CA 19-9 Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, CA-125 Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Calcitonin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Cathepsin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, CEA Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Chromogranin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Colon-Specific Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Cytokeratins Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Estrogen Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Ferritin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Gastrin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, HCG Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, 1nsulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, 1nterferons Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, 1nterleukins Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Lymphocyte Subtyping Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, NSE Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Nucleolar Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Occult Blood Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Oncogenes Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Pancreatic Oncofetal Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, PAP Smear Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Parathyroid Hormone Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Progesterone Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, PAP Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, PSA Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, S-100 Protein Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Serotonin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Sialic Acid Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Squamous Cell Carcinoma Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, TDT Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Thymidine Kinase Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Thyroglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, TPA, Test 5olume and Diagnostics Sales Forecast by Market Segment
Japan, Total Tumor Marker Sales by Major Suppliers
Japan, AFP Testing Market Diagnostics Sales by Major Supplier
Japan, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Japan, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics Sales by Major Supplier
Japan, PAP Testing Market Diagnostics Sales by Major Supplier
Japan, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Spain, Total Tumor Marker Test 5olume and Sales Forecast by Market Segment
Spain, Estimated Cancer Death Rates Per 100,000 Population
Spain, Laboratories Performing Tumor Marker Tests by Market Segment
Spain, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Spain, Commercial/Private Laboratories Performing Tumor Markers by Annual Test 5olume
Spain, Total Tumor Marker Test 5olume Forecast by Market Segment
Spain, All Market Segment Major Cancer Diagnostic Test 5olume Forecast
Spain, Hospital Laboratories Major Cancer Diagnostic Test 5olume Forecast by Test
Spain, Commercial/Private Laboratories Major Tumor Marker Test 5olume Forecast
Spain, Total Tumor Marker Sales Forecast by Market Segment
Spain, All Market Segments Major Tumor Marker Sales Forecast by Test
Spain, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
Spain, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Spain, AFP Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Beta-2 Microglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, CA 15-3 Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, CA 19-9 Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, CA-125 Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Calcitonin Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, CEA Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Colon-Specific Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Estrogen Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Ferritin Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Gastrin Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, HCG Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, 1nsulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Lymphocyte Subtyping Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, NSE Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Occult Blood Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Oncogenes Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Pancreatic Oncofetal Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, PAP Smear Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Parathyroid Hormone Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Progesterone Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, PAP Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, PSA Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, S-100 Protein Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Serotonin Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Sialic Acid Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Squamous Cell Carcinoma Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, TDT Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Thymidine Kinase Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Thyroglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, TPA Test 5olume and Diagnostics Sales Forecast by Market Segment
Spain, Total Tumor Marker Sales by Major Suppliers
Spain, AFP Testing Market Diagnostics Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
Spain, CEA Testing Market Diagnostics Sales by Major Supplier
Spain, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: U.K., Total Tumor Marker Test 5olume and Sales Forecast by Market Segment
U.K., Estimated Cancer Death Rates Per 100,000 Population
U.K., Laboratories Performing Tumor Marker Tests by Market Segment
U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test 5olume
U.K., Total Tumor Marker Testing 5olume Forecast by Market Segment
U.K., All Market Segments Major Tumor Marker Test 5olume Forecast
U.K., Hospital Laboratories Major Tumor Marker Test 5olume Forecast by Test
U.K., Commercial/Private Laboratories Major Tumor Marker Test 5olume Forecast
U.K., Total Tumor Marker Sales Forecast by Market Segment
U.K., All Market Segments Major Tumor Marker Sales Forecast by Test
U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
U.K., ACTH Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., AFP Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Beta-2 Microglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., CA 15-3/27.29 Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., CA 19-9 Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., CA-125 Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Calcitonin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., CEA Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Chromogranin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Colon-Specific Antigen Test 5olume and Diagnostics Sales by Market Segment
U.K., Cytokeratins Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Estrogen Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Ferritin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Gastrin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., HCG Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., 1nsulin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Lymphocyte Subtyping Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., NSE Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Occult Blood Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Oncogenes Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Pancreatic Oncofetal Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., PAP Smear Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Parathyroid Hormone Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Progesterone Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., PAP Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., PSA Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., S-100 Protein Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Serotonin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Sialic Acid Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Squamous Cell Carcinoma Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., TDT Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Thymidine Kinase Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Thyroglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., TPA Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K., Total Tumor Marker Sales and Market Shares Forecast
U.K., CEA Testing Market Diagnostics Sales by Major Supplier
U.K., PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: U.S., Total Tumor Marker Test 5olume and Sales Forecast By Market Segment
U.S., Estimated New Cancer Cases and Deaths
U.S., Estimated Cancer Death Rates Per 100,000 Population
U.S., Laboratories Performing Tumor Marker Tests by Market Segment
U.S., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
U.S., Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test 5olume
U.S., Physician Office Laboratories Performing Tumor Marker Tests By Practice Size
U.S., Total Tumor Marker Test 5olume Forecast by Market Segment
U.S., All Market Segments Major Tumor Marker Test 5olume Forecast
U.S., Hospital Laboratories Major Tumor Marker Test 5olume Forecast by Test
U.S., Commercial/Private Laboratories Major Tumor Marker Test 5olume Forecast
U.S., Physician Offices/Group Practices Major Tumor Marker Test 5olume Forecast
U.S., Cancer Clinics Major Tumor Marker Test 5olume Forecast by Test
U.S., Total Tumor Marker Sales Forecast by Market Segment
U.S., All Market Segment Major Tumor Marker Sales Forecast by Test
U.S., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
U.S., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
U.S., Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
U.S., Cancer Clinics Major Tumor Marker Sales Forecast by Test
U.S., ACTH Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., AFP Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Beta-2 Microglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., CA 15-3/27.29 Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., CA 19-9 Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., CA-125 Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Calcitonin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Cathepsin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., CEA Test 5olume and Diagnostics Sales by Market Segment
U.S., Chromogranin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Colon-specific Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Cytokeratins Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Estrogen Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Ferritin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Gastrin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., HCG Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., 1nsulin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., 1nterferons Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., 1nterleukins Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Lymphocyte Subtyping Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., NSE Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Nucleolar Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Occult Blood Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Oncogenes Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Pancreatic Oncofetal Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., PAP Smear Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Parathyroid Hormone Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Progesterone Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., PAP Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., PSA Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., S-100 Protein Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Serotonin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Sialic Acid Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Squamous Cell Carcinoma Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., TDT Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Thymidine Kinase Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Thyroglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., TPA Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S., Total Tumor Marker Sales By Major Supplier
U.S., ACTH Testing Market Diagnostics Sales by Major Supplier
U.S., AFP Testing Market Diagnostics Sales by Major Supplier
U.S., Beta-2 Migroblolulin Testing Market Diagnostics Sales by Major Supplier
U.S., CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 19-9 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier
U.S., CEA Testing Market Diagnostics Sales by Major Supplier
U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier
U.S., HCG Testing Market Diagnostics Sales by Major Supplier
U.S., 1nsulin Testing Market Diagnostics Sales by Major Supplier
U.S., Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
U.S., PAP Testing Market Diagnostics Sales by Major Supplier
U.S., Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
U.S., PSA Testing Market Diagnostics Sales by Major Supplier
